AstraZeneca Retained Earnings (Accumulated Deficit) 2010-2024 | AZN
AstraZeneca retained earnings (accumulated deficit) for the quarter ending September 30, 2024 were $3.138B, a 823.04% decline year-over-year.
- AstraZeneca retained earnings (accumulated deficit) for 2023 were $1.502B, a 361.67% decline from 2022.
- AstraZeneca retained earnings (accumulated deficit) for 2022 were $-0.574B, a 133.57% decline from 2021.
- AstraZeneca retained earnings (accumulated deficit) for 2021 were $1.71B, a 67.73% decline from 2020.